January 10, 2019
Rose
Sen. Chuck Grassley (R-Iowa) was one of a handful of lawmakers who have introduced legislation to curb high drug costs in the first few weeks of Congress being back in session. The topic is seen as one of only a few bipartisan issues that may get addressed by a divided Congress this year. In other pharmaceutical news, government officials are worried that drugmakers are using scare tactics to keep competition out of the marketplace.
from Kaiser Health News http://bit.ly/2siosRM
January 10, 2019
Rose
Health News, Kaiser Health News
No comments
Flurry Of Movement On Capitol Hill On Drug Pricing May Signal Possible Rough Waters Ahead For Pharma
Related Posts:
Longer Looks: New York And Surprise Medical Bills; The Fertility Doctor’s Secret; And Medicare For America- She Was Dancing On The Roof And Talking Gibberish. A Special Kind Of ER Helped Her.
- Different Takes: Lessons On The Health Law’s Success In Cost Control; Bernie’s Onto Something About Women Being Better Off Giving Birth In Finland
- Must-Reads Of The Week (Some Flying Below The Radar)
- Viewpoints: Doctors Need To Stop Saying No To Patients Who Need Opioids; FDA’s E-Cigarette Policies Could Make It Tough On U.S. Troops
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment